Q1 2023 Holdings
Filed 2023-05-15 | 108 holdings | $122.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seagen Inc(SGENUSD) | COM | 81181C104 | $4.4M | 21,948 | 3.6% |
| Ishares TR(IWD) | RUS 1000 VAL ETF | 464287598 | $4.2M | 27,900 | 3.5% |
| Coupang Inc(CPNG) | CL A | 22266T109 | $4.1M | 256,264 | 3.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $3.7M | 60,774 | 3.1% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $3.5M | 89,400 | 2.8% |
| Activision Blizzard Inc(ATVIEUR) | COM | 00507V109 | $3.4M | 40,000 | 2.8% |
| Albertsons COS Inc(ACI) | COMMON STOCK | 013091103 | $3.2M | 154,000 | 2.6% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $3.2M | 29,000 | 2.6% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.0M | 347,786 | 2.5% |
| Vmware Inc(VMWEUR) | CL A COM | 928563402 | $2.9M | 23,600 | 2.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.7M | 121,834 | 2.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $2.6M | 122,201 | 2.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.6M | 39,111 | 2.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.5M | 163,799 | 2.1% |
| Tegna Inc(TGNA) | COM | 87901J105 | $2.4M | 144,000 | 2.0% |
| Black Knight Inc(BKIEUR) | COM | 09215C105 | $2.4M | 42,200 | 2.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.4M | 94,909 | 2.0% |
| First Horizon Corporation(FHN) | COM | 320517105 | $2.4M | 135,400 | 2.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $2.4M | 98,094 | 1.9% |
| Prometheus Biosciences Inc | COM | 74349U108 | $2.2M | 20,955 | 1.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.1M | 129,245 | 1.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.0M | 183,984 | 1.6% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $2.0M | 93,375 | 1.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.0M | 92,434 | 1.6% |
| Dice Therapeutics Inc | COM | 23345J104 | $1.9M | 67,357 | 1.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.7M | 146,854 | 1.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $1.7M | 54,280 | 1.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $1.6M | 164,890 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.6M | 197,803 | 1.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.2M | 102,431 | 1.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $1.1M | 49,495 | 0.9% |
| Salesforce Inc(CRM) | COM | 79466L302 | $1.1M | 5,610 | 0.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.1M | 7,713 | 0.9% |
| Microsoft Corp(MSFT) | COM | 594918104 | $1.0M | 3,640 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.0M | 55,574 | 0.9% |
| Invesco DB Commdy Indx Trck(DBC) | UNIT | 46138B103 | $1.0M | 42,396 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $958.3K | 47,723 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $943.3K | 9,701 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $906.9K | 25,340 | 0.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $905.3K | 34,035 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $890.2K | 24,742 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $885.3K | 11,058 | 0.7% |
| Alphabet Inc(GOOG) | CAP STK CL C | 02079K107 | $884.0K | 8,500 | 0.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $869.2K | 2,333 | 0.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $857.4K | 77,314 | 0.7% |
| Merus N V | COM | N5749R100 | $845.6K | 45,957 | 0.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $812.5K | 4,056 | 0.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $801.0K | 16,535 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $790.0K | 23,583 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $786.8K | 7,338 | 0.6% |